.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
Teva
US Army
Healthtrust
McKesson
Johnson and Johnson
AstraZeneca
Dow

Generated: September 25, 2017

DrugPatentWatch Database Preview

Alectinib hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for alectinib hydrochloride and what is the scope of alectinib hydrochloride patent protection?

Alectinib hydrochloride
is the generic ingredient in one branded drug marketed by Hoffmann-la Roche and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Alectinib hydrochloride has fifty-two patent family members in thirty-one countries.

One supplier is listed for this compound.

Summary for Generic Name: alectinib hydrochloride

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list12
Clinical Trials: see list2,294
Patent Applications: see list5
Drug Prices:see low prices
DailyMed Link:alectinib hydrochloride at DailyMed

Pharmacology for Ingredient: alectinib hydrochloride

Drug ClassKinase Inhibitor
Mechanism of ActionKinase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Hoffmann-la Roche
ALECENSA
alectinib hydrochloride
CAPSULE;ORAL208434-001Dec 11, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alectinib hydrochloride

Country Document Number Estimated Expiration
TaiwanI526441► Subscribe
Spain2575084► Subscribe
European Patent Office2975024► Subscribe
Brazil112013003879► Subscribe
Poland2441753► Subscribe
Taiwan201613858► Subscribe
Singapore175707► Subscribe
Colombia6430460► Subscribe
European Patent Office2441753► Subscribe
Mexico2013001989► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Covington
Deloitte
QuintilesIMS
Dow
Cipla
McKesson
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot